Blue light induced ferroptosis via STAT3/GPX4/SLC7A11/FTH1 in conjunctiva epithelium in vivo and in vitro

The prevalence of Light -emitting diodes (LEDs) has exposed us to an excessive amount of blue light (BL) which causes various ophthalmic diseases. Previous studies have shown that conjunctiva is vulnerable to BL. In this study, we aimed to investigate the underlying mechanism of BL -induced injury in conjunctiva. We placed C57BL/ 6 mice and human conjunctival epithelial cell lines (HCECs) under BL (440 nm +/- 15 nm, 0.2 mW/cm 2 ) to establish a BL injury model in vivo and in vitro . Immunohistochemistry and MDA assay were used to identify lipid peroxidation (LPO) in vivo . HE staining was applied to detect morphological damage of conjunctival epithelium. DCFH-DA, C11-BODIPY 581/591, Calcein-AM, and FeRhoNox TM-1 probes were performed to identify ferroptosis levels in vitro . Real-time qPCR and Western blotting techniques were employed to uncover signaling pathways of blue light -induced ferroptosis. Our findings demonstrated that BL affected tear film instability and induced conjunctival epithelium injury in vivo . Ferrostatin-1 significantly alleviated blue light -induced ferroptosis in vivo and in vitro . BL downregulates the levels of solute carrier family 7 member 11 (SLC7A11), Ferritin heavy chain (FTH1), and glutathione peroxidase (GPX4) by inhibiting the activation and translocation of the Signal transducer and activator of transcription 3 (STAT3) from inducing Fe 2 + burst, ROS and LPO accumulation, ultimately resulting in ferroptosis. This study will offer new insight into BL -induced conjunctival injury and LED -induced dry eye.